BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magni G, Ceruti S. The role of adenosine and P2Y receptors expressed by multiple cell types in pain transmission. Brain Res Bull 2019;151:132-43. [PMID: 30797817 DOI: 10.1016/j.brainresbull.2019.02.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
2 Jiang Y, Lin J, Zheng H, Zhu P. The Role of Purinergic Signaling in Heart Transplantation. Front Immunol 2022;13:826943. [DOI: 10.3389/fimmu.2022.826943] [Reference Citation Analysis]
3 Xu G, Zhang S, Zheng L, Hu Z, Cheng L, Chen L, Li J, Shi Z. In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulations. Purinergic Signal 2021. [PMID: 34677752 DOI: 10.1007/s11302-021-09808-4] [Reference Citation Analysis]
4 Metzner K, Gross T, Balzulat A, Wack G, Lu R, Schmidtko A. Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice. Purinergic Signal 2021;17:503-14. [PMID: 34313915 DOI: 10.1007/s11302-021-09806-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Magni G, Ceruti S. Purines in Pain as a Gliopathy. Front Pharmacol 2021;12:649807. [PMID: 33790798 DOI: 10.3389/fphar.2021.649807] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ceruti S. From astrocytes to satellite glial cells and back: A 25 year-long journey through the purinergic modulation of glial functions in pain and more. Biochem Pharmacol 2021;187:114397. [PMID: 33382970 DOI: 10.1016/j.bcp.2020.114397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Trapero C, Martín-Satué M. Purinergic Signaling in Endometriosis-Associated Pain. Int J Mol Sci 2020;21:E8512. [PMID: 33198179 DOI: 10.3390/ijms21228512] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Magni G, Pedretti S, Audano M, Caruso D, Mitro N, Ceruti S. Glial cell activation and altered metabolic profile in the spinal-trigeminal axis in a rat model of multiple sclerosis associated with the development of trigeminal sensitization. Brain Behav Immun 2020;89:268-80. [PMID: 32659316 DOI: 10.1016/j.bbi.2020.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zhao J, Li H, Shi C, Yang T, Xu B. Electroacupuncture Inhibits the Activity of Astrocytes in Spinal Cord in Rats with Visceral Hypersensitivity by Inhibiting P2Y1 Receptor-Mediated MAPK/ERK Signaling Pathway. Evid Based Complement Alternat Med 2020;2020:4956179. [PMID: 32184891 DOI: 10.1155/2020/4956179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Bán EG, Brassai A, Vizi ES. The role of the endogenous neurotransmitters associated with neuropathic pain and in the opioid crisis: The innate pain-relieving system. Brain Res Bull 2020;155:129-36. [PMID: 31816407 DOI: 10.1016/j.brainresbull.2019.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
11 Engel T, Sperlagh B. Purinergic signaling as a target for emerging neurotherapeutics. Brain Res Bull 2019;151:1-2. [PMID: 31163189 DOI: 10.1016/j.brainresbull.2019.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]